We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $189M Turnover 22.11%
1-Year Est. Return 67.72%
This Fund
S&P 500
This Quarter Est. Return
+14.16%
1 Year Est. Return
+67.72%
3 Year Est. Return
+169.37%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$277M
AUM Growth
-$8.05M
Cap. Flow
-$5.69M
Cap. Flow %
-2.06%
Top 10 Hldgs %
77.48%
Holding
98
New
6
Increased
9
Reduced
11
Closed
9
Avg Time Held
2 years
Top 10 Avg Time Held
1.3 years
Top 20 Avg Time Held
1.3 years

Top Buys

Rank Stock Value
1
JAAA icon
Janus Henderson AAA CLO ETF
JAAA
+$25.7M
2
COLL icon
Collegium Pharmaceutical
COLL
+$1.09M
3
PFE icon
Pfizer
PFE
+$814K
4
MDT icon
Medtronic
MDT
+$693K
5
HELP
Helus Pharma Inc. Common Stock
HELP
+$614K

Top Sells

Rank Stock Value
1
CLMT icon
Calumet Specialty Products
CLMT
+$14.2M
2
CLOZ icon
Panagram BBB-B CLO ETF
CLOZ
+$13.3M
3
GSK icon
GSK
GSK
+$2.66M
4
DMRC icon
Digimarc Corp
DMRC
+$2.25M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$1.89M

Sector Composition

Rank Sector Weight
1 Materials 29.62%
2 Healthcare 26.2%
3 Financials 16.91%
4 Miscellaneous 16.47%
5 Communication Services 7.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
RHP icon
26
Ryman Hospitality Properties
RHP
$8.69B
$1.25M 0.45%
12,000
– –
2021 Q4
12 quarters
MREO icon
27
Mereo BioPharma
MREO
$48.4M
$1.16M 0.42%
331,000
– –
2024 Q1
3 quarters
ATYR icon
28
aTyr Pharma
ATYR
$17.1M
$1.12M 0.4%
308,133
+200,959
+188% +$608K
2024 Q3
1 quarter
COLL icon
29
Collegium Pharmaceutical
COLL
$755M
$943K 0.34%
+32,927
New +$1.09M
2024 Q4
0 quarters
XBI icon
30
State Street SPDR S&P Biotech ETF
XBI
$9.54B
$901K 0.33%
10,000
– –
2023 Q4
4 quarters
ABBV icon
31
AbbVie
ABBV
$504B
$895K 0.32%
5,037
– –
2021 Q4
12 quarters
XENE icon
32
Xenon Pharmaceuticals
XENE
$3.24B
$818K 0.3%
20,866
– –
2021 Q4
12 quarters
VRTX icon
33
Vertex Pharmaceuticals
VRTX
$127B
$805K 0.29%
2,000
– –
2021 Q4
12 quarters
KMB icon
34
Kimberly-Clark
KMB
$35.1B
$786K 0.28%
6,000
– –
2021 Q4
12 quarters
DD icon
35
DuPont de Nemours
DD
$17.6B
$757K 0.27%
7,911
– –
2021 Q4
12 quarters
MSFT icon
36
Microsoft
MSFT
$3.93T
$674K 0.24%
1,600
– –
2021 Q4
12 quarters
CTVA icon
37
Corteva
CTVA
$8.59B
$659K 0.24%
11,563
– –
2021 Q4
12 quarters
MDT icon
38
Medtronic
MDT
$121B
$639K 0.23%
+8,000
New +$693K
2024 Q4
0 quarters
EOLS icon
39
Evolus
EOLS
$469M
$636K 0.23%
57,570
– –
2023 Q1
7 quarters
AAPL icon
40
Apple
AAPL
$5.01T
$625K 0.23%
2,494
– –
2021 Q4
12 quarters
MGTX icon
41
MeiraGTx Holdings
MGTX
$891M
$579K 0.21%
95,080
+90,377
+1,922% +$530K
2024 Q3
1 quarter
MDLZ icon
42
Mondelez International
MDLZ
$81.6B
$538K 0.19%
9,000
– –
2021 Q4
12 quarters
HELP
43
Helus Pharma Inc. Common Stock
HELP
$771M
$533K 0.19%
+60,446
New +$614K
2024 Q4
0 quarters
CNQ icon
44
Canadian Natural Resources
CNQ
$111B
$519K 0.19%
16,800
– –
2021 Q4
12 quarters
XOMA icon
45
DELISTED
Xoma
XOMA
$518K 0.19%
19,722
– –
2022 Q4
8 quarters
VRDN icon
46
Viridian Therapeutics
VRDN
$2.16B
$479K 0.17%
+25,000
New +$544K
2024 Q4
0 quarters
IBM icon
47
IBM
IBM
$219B
$471K 0.17%
2,142
– –
2023 Q1
7 quarters
BMRN icon
48
BioMarin Pharmaceuticals
BMRN
$10.6B
$381K 0.14%
5,800
-28,200
-83% -$1.89M
2024 Q3
1 quarter
LLY icon
49
Eli Lilly
LLY
$1.12T
$232K 0.08%
300
– –
2021 Q4
12 quarters
NVDA icon
50
NVIDIA
NVDA
$5.17T
$172K 0.06%
1,280
– –
2022 Q2
10 quarters
1
2
3 4

Similar funds

SCA
Sander Capital Advisors Seattle, Washington $189M AUM 13.06% 1-Year Est. Return
FI
FWG Investments Lexington, Kentucky $189M AUM 18.47% 1-Year Est. Return
MFS
Madrid Financial Services Manhattan Beach, California $189M AUM 30.12% 1-Year Est. Return
FRA
FFG Retirement Advisors Centennial, Colorado $189M AUM 16.39% 1-Year Est. Return
CAM
Councilmark Asset Management Knoxville, Tennessee $189M AUM 26.93% 1-Year Est. Return
BAG
Bauman Advisory Group Las Vegas, Nevada $189M AUM
SHC
SALT Holding Corp Wilmington, Delaware $189M AUM 34.63% 1-Year Est. Return
HC
Hara Capital Bellevue, Washington $190M AUM 42.56% 1-Year Est. Return

David M. Knott Jr's Q4 2024 Portfolio in Review

As of Q4 2024, David M. Knott Jr held 98 positions worth $277M, down 2.8% from $285M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

David M. Knott Jr's Q4 2024 filing shows 6 new, 9 increased, 11 reduced and 9 closed positions. Its largest new stake was Collegium Pharmaceutical: 32,927 shares worth $943K. The largest sale was Calumet Specialty Products, an estimated $14.2M.

By sector, the portfolio is most concentrated in Materials at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.

  • David M. Knott Jr's largest Q4 2024 buy was Collegium Pharmaceutical: 32,927 shares worth $943K.
  • David M. Knott Jr added most to Janus Henderson AAA CLO ETF in Q4 2024, an estimated $25.7M increase.
  • David M. Knott Jr's biggest Q4 2024 reduction was Calumet Specialty Products, cutting an estimated $14.2M.
  • David M. Knott Jr fully exited GSK in Q4 2024, selling an estimated $2.66M.
  • David M. Knott Jr's ten largest holdings make up 77% of its $277M portfolio in Q4 2024.
  • David M. Knott Jr opened 6 new positions and closed 9 in Q4 2024.
  • David M. Knott Jr's portfolio value fell 2.8% quarter-over-quarter to $277M.

Based on David M. Knott Jr's 13F filing for Q4 2024, filed 12 Feb 2025.